CAS: 1229096-88-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK 9027 REF: 3D-EZB09688CAS: 1229096-88-1 | Min. 95% | To inquire | Tue 03 Sep 24 |
 | GSK9027 REF: TM-T22818CAS: 1229096-88-1 | 99.36% | 59.00 €~1,663.00 € | Mon 09 Sep 24 |
 | GSK 9027 REF: TR-G797848CAS: 1229096-88-1 | - - - | - - - | Discontinued product |
GSK 9027
CAS:1229096-88-1
GSK 9027 is a conjugate of the chemotherapeutic agent gemcitabine with an antisense oligodeoxynucleotide. The …
Formula:
C27H19F4N3O2S
Purity:
Min. 95%
Molecular weight:
525.5 g/mol
Ref: 3D-EZB09688
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 3 Sep 2024
GSK9027
CAS:1229096-88-1
GSK9027, a nonsteroidal GR agonist, is a partial 2×GRE reporter gene activator, less potent than …
Formula:
C27H19F4N3O2S
Purity:
99.36%
Color and Shape:
Solid
Molecular weight:
525.52
Ref: TM-T22818
| 1mg | 59.00 € | ||
| 5mg | 123.00 € | ||
| 10mg | 198.00 € | ||
| 25mg | 416.00 € | ||
| 50mg | 600.00 € | ||
| 100mg | 828.00 € | ||
| 500mg | 1,663.00 € |
Estimated delivery in United States, on Monday 9 Sep 2024
Ref: TR-G797848
| 50mg | Discontinued | Request information |
